awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34622644-E4F58A71-160A-46F9-BECE-4CC74C95C899
Q34622644-E4F58A71-160A-46F9-BECE-4CC74C95C899
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34622644-E4F58A71-160A-46F9-BECE-4CC74C95C899
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
P2860
Q34622644-E4F58A71-160A-46F9-BECE-4CC74C95C899
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34622644-E4F58A71-160A-46F9-BECE-4CC74C95C899
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41fb8cc844f5aec0b84cb795984c8fca76b4956c
P2860
Hyperparathyroidism and renal failure.